cardiac imaging agents (Molecular Insight/University of Maryland)

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug Namecardiac imaging agents (Molecular Insight/University of Maryland)
Drug Alias Nameradiolabeled lisinopril derivatives (Molecular Insight/University of Maryland)ACE-monitoring radiopharmaceuticals (Molecular Insight/University of Maryland)MIP-1037MIP-200MIP-190
ClassificationSmall moleculesRadiation-emitting products > Radioactive diagnostic agent
Mechanisms of ActionAngiotensin-converting enzyme modulators
TargetsAngiotensin-converting enzyme
Therapy Area/IndicationsHeart Failure
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMolecular Insight Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUniversity Of MarylandMolecular Insight Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsHeart Failure

Other Information

ATC CodeN/A
Related LinksN/A